Canadian Institute For Knowledge Development
  • Register
  • Login

Canadian Journal of Medicine

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 4, Issue 1
  3. Authors

Current Issue

By Issue

By Subject

Keyword Index

Author Index

Indexing Databases XML

About Journal

Aims and Scope

Editorial Board

Indexing and Abstracting

Peer Review Process

News

Immunosenescence, COVID-19, and Vaccine Efficacy in the Elderly

    Fariha Khan Peter Anto Johnson John Christy Johnson Jasrita Singh Austin Mardon

Canadian Journal of Medicine, 2022, Volume 4, Issue 1, Pages 22-25
10.33844/cjm.2022.6017

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Recent research has unveiled and confirmed the deleterious age-related changes of the immune system which result in diminished ability of older adults to effectively respond to pathogens and infection. This degradation is defined by the term immunosenescence. Immunosenescence can also bring with it reduced vaccine efficacy. In an era where the population of older adults is growing exponentially, it is apparent why such dysfunction is concerning. Adding even more pertinence is the COVID-19 pandemic. Since March of 2020, older adults across the globe have borne witness to the disproportional effects of COVID-19 infection on their mortality rates versus younger adults and children. In order to bring the pandemic to an end, the global population must be inoculated. However, concerns have been raised about the effectiveness of the COVID-19 vaccines on the elderly. This article aims to provide a brief overview of immunosenescence, the COVID-19 pandemic, and what research has shown thus far about vaccine efficacy for older adults. As well, potential methods to combat immunosenescence will be explored.
Keywords:
    Immunosenescence COVID-19 geriatrics Vaccines Therapeutics
  • PDF (299 K)
  • XML
Fariha Khan, Peter Anto Johnson, John Christy Johnson, Jasrita Singh, Austin Mardon (2022). Immunosenescence, COVID-19, and Vaccine Efficacy in the Elderly. Canadian Journal of Medicine, 4(1), 22-25. doi: 10.33844/cjm.2022.6017
Fariha Khan; Peter Anto Johnson; John Christy Johnson; Jasrita Singh; Austin Mardon. "Immunosenescence, COVID-19, and Vaccine Efficacy in the Elderly". Canadian Journal of Medicine, 4, 1, 2022, 22-25. doi: 10.33844/cjm.2022.6017
Fariha Khan, Peter Anto Johnson, John Christy Johnson, Jasrita Singh, Austin Mardon (2022). 'Immunosenescence, COVID-19, and Vaccine Efficacy in the Elderly', Canadian Journal of Medicine, 4(1), pp. 22-25. doi: 10.33844/cjm.2022.6017
Fariha Khan, Peter Anto Johnson, John Christy Johnson, Jasrita Singh, Austin Mardon Immunosenescence, COVID-19, and Vaccine Efficacy in the Elderly. Canadian Journal of Medicine, 2022; 4(1): 22-25. doi: 10.33844/cjm.2022.6017
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 46
  • PDF Download: 41
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap
This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus